(Circulation. 1999;100:e99.)
© 1999 American Heart Association, Inc.
Circulation Electronic Pages |
Department of Invasive Cardiology Royal Brompton and Harefield NHS Trust, London, UK
| Introduction |
|---|
The Brief Rapid Communication by Maron et al1 describing in greater detail a variant of hypertrophic obstructive cardiomyopathy significantly adds to our knowledge of this intriguing disease.
The point is very well taken: hypertrophic obstructive cardiomyopathy is not one single entity! Every case has its very own problems, and there are hardly 2 cases alike.
In their discussion, the authors raise the important question of whether nonsurgical techniques2 3 4 could possibly deal with this particular variant. Certainly, from their surgical illustrations, it appears as if transluminal techniques could be considered in this situation. All myocardium is supplied by coronary arteries, and if the supply arteries of the myectomy territory can be properly identified, it should be possible to deal with this problem by transluminal myocardial reduction with alcohol.
A number of cases of midventricular obstruction have now been successfully dealt with by nonsurgical myocardial reduction.5 In the cases presented by Maron et al,1 it is conceivable that such a procedure would be as effective or almost as effective as surgery.
It would be most helpful to see the coronary angiogram performed before surgery in these 2 patients, but it is normally possible to cannulate the supply arteries in these cases. The issue that remains unresolved, however, is how much the papillary muscle itself contributes to the outflow tract gradient, because it is unlikely that this could be modified by nonsurgical techniques.
| References |
|---|
2. Sigwart U. Nonsurgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346:211214.[Medline] [Order article via Infotrieve]
3.
Knight C, Kurbaan AS, Seggewiss H, Henein M, Gunning
M, Harrington D, Fassbender D, Gleichmann U, Sigwart U. Nonsurgical
septal reduction for hypertrophic obstructive
cardiomyopathy: outcome in the first series of
patients. Circulation. 1997;95:20752081.
4. Seggewiss H, Faber L, Kurbaan A, Sigwart U. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. In: Topol EJ, ed. Textbook of Interventional Cardiology. 3rd ed. Philadelphia, Pa: WB Saunders; 1999;47:878886.
5. Brookes C, Stables R, Sigwart U. Massive septal hypertrophy with no outflow tract gradient: an indication for alcohol ablation? 2nd European Workshop on Hypertrophic Obstructive Cardiomyopathy. Bad Oeynhausen, Germany, October 30, 1998. Abstract.
Minneapolis Heart Institute Foundation Minneapolis, Minn
Mayo Clinic, Rochester, Minn
| Introduction |
|---|
We appreciate Dr Sigwarts interest in our observations
regarding the surgical management of obstructive hypertrophic
cardiomyopathy (HCM)
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |